Blood Sugar & Insulin Sensitivity
What does the research show about carbohydrate restriction and blood-sugar markers, and what are the cautions?
Copper Keto Companion collects the trials and the official guidance on carbohydrate restriction and blood sugar here. This is the most medically sensitive topic, so the entries lead with the safety cautions and report effects strictly as the studies measured them.
Contents — 8 entries
- 📄 Low and Very-Low-Carbohydrate Diets for Type 2 Diabetes Remission (Meta-Analysis)
- 📄 Very-Low-Carbohydrate (Ketogenic) Diets in Type 2 Diabetes (Meta-Analysis)
- 📄 Dietary Approaches and Glycemic Control in Type 2 Diabetes (Network Meta-Analysis)
- 📄 A 3-Week Ketogenic Diet and Skeletal-Muscle Insulin Sensitivity (Crossover RCT)
- 🏢 Nutrition Therapy for Adults With Diabetes or Prediabetes (ADA Consensus Report)
- 📄 Two-Year Outcomes of a Continuous-Care Intervention Including Nutritional Ketosis (Type 2 Diabetes)
- 📄 Dietary Carbohydrate Restriction in Type 2 Diabetes (Meta-Analysis)
- 📄 Low-Carbohydrate Diet, Glucose and Lipid Metabolism in Overweight or Obese Type 2 Diabetes (Meta-Analysis)
📄 Low and Very-Low-Carbohydrate Diets for Type 2 Diabetes Remission (Meta-Analysis)
Goldenberg JZ, et al. — BMJ, 2021 · BMJ, 2021
Copper Keto Companion research surfaced this report because it covers low-carb diets and blood-sugar markers in type 2 diabetes. The 2021 BMJ meta-analysis of 23 trials and 1,357 participants reported that at six months more people met a diabetes-remission threshold on low-carb (57% versus 31%; risk difference 0.32, 95% CI 0.17 to 0.47); at twelve months the authors note remission data were sparse, ranging from a small effect to a trivial increased risk. They conclude, on moderate-to-low-certainty evidence, that six months of a low-carb diet may bring remission without adverse consequences.
What it examines: pooled RCT data on low-carb diets and glycemic outcomes in type 2 diabetes. Why it's in the Copper Keto Companion research index: a meta-analysis of low-carb diets, diabetes remission, and glycemic markers.
📄 Very-Low-Carbohydrate (Ketogenic) Diets in Type 2 Diabetes (Meta-Analysis)
Parry-Strong A, et al. — Diabetes, Obesity and Metabolism, 2022 · Diabetes Obes Metab, 2022
Copper Keto Companion research surfaced this report because it covers ketogenic diets and longer-term blood sugar in pre-diabetes or type 2 diabetes. Pooling 8 ketogenic-diet RCTs in 606 people with pre-diabetes or type 2 diabetes, the 2022 analysis found mixed twelve-month HbA1c results — four studies showed essentially no difference versus comparison diets (+0.01%, p=.91) while two showed a reduction (-0.65%, p<.001) — with triglycerides lower (-0.28 mmol/L) and HDL slightly higher (+0.04 mmol/L). The authors conclude the evidence of an advantage over other diets is limited and call for more well-designed trials.
What it examines: ketogenic-specific RCTs and their 12-month glycemic results in pre-diabetes or type 2 diabetes. Why it's in the Copper Keto Companion research index: a meta-analysis of ketogenic-specific trials and 12-month glycemic outcomes.
📄 Dietary Approaches and Glycemic Control in Type 2 Diabetes (Network Meta-Analysis)
Jing T, et al. — Nutrients, 2023 · Nutrients, 2023
Copper Keto Companion research surfaced this report because it covers how low-carb ranks against other eating patterns for blood sugar. The 2023 network meta-analysis of 42 trials and 4,809 participants estimated a low-carbohydrate diet lowered HbA1c by about 0.69 points versus control, with the certainty of its estimates assessed using the GRADE approach. The authors note that long-term, high-quality data are limited and call for further long-term studies.
What it examines: a network meta-analysis ranking dietary patterns by glycemic effect. Why it's in the Copper Keto Companion research index: a network meta-analysis ranking dietary patterns by glycemic effect.
📄 A 3-Week Ketogenic Diet and Skeletal-Muscle Insulin Sensitivity (Crossover RCT)
Luong TV, et al. — Diabetes (ADA), 2024 · Diabetes, 2024
Copper Keto Companion research surfaced this report because it covers a proposed mechanism linking keto and insulin sensitivity. In a randomized crossover trial of 11 adults with obesity and without diabetes, three weeks of a ketogenic diet raised the glucose disposal rate during an insulin clamp, a marker of improved muscle insulin sensitivity. The study is small and short, measured a secondary marker rather than a clinical outcome, and ran alongside 2.2 kg of weight loss that confounds the result.
What it examines: a mechanistic clamp study of short-term keto and insulin sensitivity. Why it's in the Copper Keto Companion research index: a mechanistic clamp study of short-term keto and insulin sensitivity.
🏢 Nutrition Therapy for Adults With Diabetes or Prediabetes (ADA Consensus Report)
Evert AB, et al. — Diabetes Care (American Diabetes Association), 2019 · Diabetes Care, 2019
Copper Keto Companion research surfaced this report because it covers official diabetes-organization guidance on carbohydrate restriction and its cautions. The American Diabetes Association's 2019 consensus report states that low-carb and very-low-carb patterns have been shown to reduce HbA1c and medication needs, while stressing that no single eating pattern suits everyone. It is direct about the risk: a very-low-carb plan can cause diuresis and a swift drop in blood glucose, so a knowledgeable practitioner should be involved at the start to prevent dehydration and to reduce insulin or other medication and avoid hypoglycemia.
What it examines: a major diabetes body's position on carbohydrate restriction and its cautions. Why it's in the Copper Keto Companion research index: a diabetes-organization consensus report on carbohydrate restriction and its cautions.
📄 Two-Year Outcomes of a Continuous-Care Intervention Including Nutritional Ketosis (Type 2 Diabetes)
Athinarayanan SJ, et al. — Frontiers in Endocrinology, 2019 (non-randomized; industry-funded) · Front Endocrinol, 2019
Copper Keto Companion research surfaced this report because it covers a supervised two-year ketosis program's blood-sugar and medication outcomes. In an open-label, non-randomized program of 262 supervised participants, this two-year study found HbA1c about 12% below baseline and fasting insulin roughly 42% lower. It was not randomized, which weakens any causal claim, and it was funded by the company that ran the program, so it stands as an outcome under intensive medical supervision and not as evidence that a diet treats or reverses diabetes.
What it examines: a supervised two-year ketosis program's glycemic and medication outcomes. Why it's in the Copper Keto Companion research index: a non-randomized two-year study of a supervised ketosis program's glycemic and medication outcomes.
📄 Dietary Carbohydrate Restriction in Type 2 Diabetes (Meta-Analysis)
Snorgaard O, et al. — BMJ Open Diabetes Research & Care, 2017 · pubmed / 28316796
Copper Keto Companion research surfaced this report because it covers how the degree of carbohydrate restriction tracks with blood-sugar control. The 2017 meta-analysis of 10 trials and 1,376 people with type 2 diabetes found low-carb diets lowered HbA1c by about 0.34% in the first year versus higher-carb diets, with a dose-response by degree of restriction, but at one year or later HbA1c was similar between the groups. The longer-term comparison rested on fewer trials.
What it examines: a meta-analysis of carbohydrate-restriction degree and HbA1c in type 2 diabetes. Why it's in the Copper Keto Companion research index: a meta-analysis on whether the amount of carbohydrate restriction affects blood-sugar control over time.
📄 Low-Carbohydrate Diet, Glucose and Lipid Metabolism in Overweight or Obese Type 2 Diabetes (Meta-Analysis)
Tian W, et al. — Frontiers in Nutrition, 2025 · Front Nutr, 2025
Copper Keto Companion research surfaced this report because it covers a recent pooling of low-carb trials in overweight or obese type 2 diabetes. Across 17 randomized trials and 1,197 participants, the 2025 meta-analysis found a low-carbohydrate diet lowered HbA1c by 0.36 percentage points (95% CI -0.44 to -0.29), fasting glucose by 10.71 mg/dL, and triglycerides, and raised HDL; LDL cholesterol did not change significantly in this group (+2.61 mg/dL, 95% CI -0.64 to 5.86, p=0.12), who also lost about 3.71 kg. The authors flag variable diet definitions and reliance on self-reported intake as limitations.
What it examines: 17 RCTs pooling low-carb effects on glucose, lipids, and weight in overweight or obese type 2 diabetes. Why it's in the Copper Keto Companion research index: a 2025 meta-analysis of low-carb diets and glucose and lipid markers in overweight or obese type 2 diabetes.
All 8 sources last verified June 2026.
Frequently Asked Questions
Can a low-carb diet lower blood sugar in type 2 diabetes?
Research reports short-term improvements. A 2021 BMJ meta-analysis found more diabetes remission at six months on low-carb (57% versus 31%; risk difference 0.32, 95% CI 0.17 to 0.47), on moderate-to-low-certainty evidence, with twelve-month remission data sparse. This summarizes research and is not medical advice.
Is it safe to start keto if I take diabetes medication?
That is a medical decision for your clinician. The ADA consensus report (2019) warns that carbohydrate restriction can drop blood glucose quickly and cause hypoglycemia unless insulin or sulfonylurea doses are adjusted under supervision.
Does keto improve insulin sensitivity?
Small mechanistic studies suggest it can short-term. A 2024 crossover trial (n=11, the ADA journal Diabetes) found higher glucose disposal after three weeks of keto, but it was small, short, and confounded by concurrent weight loss.
Does keto 'reverse' diabetes?
We do not make that claim. The studies that use reversal language (e.g., Athinarayanan, 2019) are non-randomized, industry-funded supervised programs; they report medication reductions, which is not the same as evidence that a diet treats the disease.
Does keto's blood-sugar benefit come with a downside?
It can. The same research that shows lower triglycerides and higher HDL on a ketogenic diet also shows LDL cholesterol often rises, sometimes substantially — a separate cardiovascular question covered in the keto-adaptation research, where mainstream cardiology treats a sustained LDL rise as a real risk signal. Blood-sugar change and lipid change are distinct, and the lipid side is where the evidence is most contested.
More in Keto Research
Educational information only — not medical advice, and not a recommendation to start, stop, or change any diet, supplement, or treatment. Talk to a qualified healthcare professional before making changes. Copper Keto Companion and Copper Sun Content and Creative, LLC are not medical providers.